Cheng, Jin-Wei <br/><br/>
Ranibizumab for age-related macular degeneration.  [electronic resource] 

 -  The New England journal of medicine  02 2011 
 - 582 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1533-4406 
<br/><br/><label>Standard No.: </label>10.1056/NEJMc1013316  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--adverse effects<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>Bevacizumab<br/>Humans<br/>Injections, Intraocular<br/>Ranibizumab<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Wet Macular Degeneration--drug therapy